NCT04865770: A Research Study to Find Out How Semaglutide Works in the Kidneys Compared to Placebo, in People With Type 2 Diabetes and Chronic Kidney Disease (the REMODEL Trial)
- State
- Completed
- Phase
- Phase 3
- People
- 106 taking part
- Started
- 28 Apr 2021
- Primary completion
- 21 Nov 2024
- Arms
- Semaglutide 1.0 mg OW
- Results
- Posted on the registry
- 28 Apr 2021: Trial started
- 29 Apr 2021: Trial registered
- 21 Nov 2024: Trial completed
- 14 Jan 2026: Trial results posted